News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SLG-Giant Pharm, a China CRO, to Run China Arm of US National Institutes of Health (NIH) Trial


11/2/2012 3:09:33 PM

October 31, 2012 -- SLG-Giant Pharm Service Group, a China physician-owned clinical-stage CRO, was granted a full-service contract to conduct the China arm of the ATACH-II trial by the US National Institute of Health. According to SLG-Giant, this is the first NIH supported clinical trial with sites outside the US. Around the globe, ATACH-II will enroll 1200 patients. More details....

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES